Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, originally extracted from the periwinkle plant (Vinca minor). It has been used in several countries, especially in Eastern Europe, as a treatment for cerebrovascular disorders, including stroke. The rationale for its use is based on its purported neuroprotective, vasodilatory, and anti-inflammatory effects. Vinpocetine is thought to increase cerebral blood flow, inhibit voltage-gated sodium channels, and suppress excessive glutamate release, potentially limiting neuronal damage after ischemic stroke.

Clinical trials investigating vinpocetine for stroke have produced mixed results. Some small-scale studies and open-label trials suggest modest improvements in cognitive function and neurological status in stroke patients, but these studies often have methodological limitations, such as small sample sizes, lack of rigorous controls, and short follow-up periods. Systematic reviews and meta-analyses have generally concluded that there is insufficient high-quality evidence to recommend vinpocetine for acute stroke treatment or prevention. Major Western guidelines do not recommend its use, and the U.S. FDA has raised concerns about its safety and efficacy.

In summary, while there is a scientific rationale and some preliminary evidence for vinpocetine’s use in stroke, the overall quality of evidence is low, and its routine clinical use is not supported by robust clinical trials. Its use remains more common in countries with different regulatory standards and clinical traditions.

More about Vinpocetine
More about Strokes

Other ingredients used for Strokes

Other health conditions supported by Vinpocetine

Products containing Vinpocetine

Pure Encapsulations Vinpocetine 20 mg